VanEck Pharmaceutical ETF
PPH
#1357
ETF rank
A$1.27 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
A$150.65
Share price
1.68%
Change (1 day)
12.14%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of June 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of June 2026: 0.36%